Table 2:

Efficacy Outcomes of the efficacy population

Efficacy Outcomes: N=97
Response per IRC according to IMWG 2016
Overall Response Rate, n (%)	95 (97.9%)
(sCR+VGPR+PR)
(95% CI)	(92.7, 99.7)
Stringent Complete response, n (%)	76 (78.4%)
(95% CI)	(68.8,86.1)
Very Good Partial Response, n (%)	16 (16.5%)
(95% CI)	(9.7,25.4)
Partial Response, n (%)	3 (3.1%)
(95% CI)	(0.6,8.8)
Estimated median DOR (95% CI), (months)
All responders	21.8 (21.8, NE)

Data from source: Package insert for ciltacabtagene autoleucel⁶